Cytokines, growth factors, and plastic surgery

Plastic and Reconstructive Surgery

Volumn 108, Issue 3, 2001, Pages 719-733

  Rumalla, V K ^a   Borah, G L ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; GAMMA INTERFERON; GROWTH FACTOR; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; KERATINOCYTE GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; SOMATOMEDIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

AUTOCRINE EFFECT; CELL LINE; GENE THERAPY; HOST RESISTANCE; PARACRINE SIGNALING; PLASTIC SURGERY; PRIORITY JOURNAL; REVIEW; SCAR FORMATION; WOUND HEALING; WOUND HEALING IMPAIRMENT;

EID: 0035448963     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006534-200109010-00019     Document Type: Review

References (159)

1. Inflammation
2. Mechanisms that regulate the production and effects of tumor necrosis factor-alpha
3. Detection of circulating tumor necrosis factor after endotoxin administration
4. Interleukin 1 and tumor necrosis factor stimulate human vascular endothelial cells to promote transendothelial neutrophil passage
5. Basics of cutaneous wound repair
6. The local effects of cachectin/tumor necrosis factor on wound healing
7. Neutrophils express tumor necrosis factor-alpha during mouse skin wound healing
8. Cytokines and the cellular response to injury and infection
9. Tumor necrosis factor and interleukin- 1 in the serum of children with severe infectious purpura
10. Plasma tumor necrosis factor in patients with septic shock: Mortality rate, incidence of adult respiratory distress syndrome and effects of methylprednisolone administration
11. Cytokine-associated tissue injury and lethality in mice: A comparative study
12. Association between tumor necrosis factor in serum and fatal outcome in patients with meningococcal disease
13. Correlation of interleukin- 1 beta and cachectin concentrations in cerebrospinal fluid and outcome from bacterial meningitis
14. Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: Characterization and comparison with the actions of interleukin 1
15. Modulation of endothelial cell hemostatic properties by tumor necrosis factor
16. Host responses in mediating sepsis and adult respiratory distress syndrome
17. Cachectin/TNF-alpha in septic shock and septic adult respiratory distress syndrome
18. Tumor necrosis factor and wound healing
19. In vivo effects of tumor necrosis factor alpha on incised wound and gunshot wound healing
20. Tumor necrosis factor alpha induces invasiveness of human skin fibroblasts in vitro
21. Tumor necrosis factor alpha inhibits wound healing in the rat
22. Tumor necrosis factor-alpha selectivity modulates expression of collagen genes in rat granulation tissue
23. Rapala,K. The effect of tumor necrosis factor alpha on wound healing: An experimental study
24. Tumor necrosis factor mediates impaired wound healing in chronic abdominal sepsis
25. Tumor necrosis factor-alpha inhibits collagen alphal(I) gene expression and wound healing in a murine model of cachexia
26. Levels of tumor necrosis factor-alpha (TNF-alpha) and soluble TNF receptors in chronic venous leg ulcers: Correlations to healing status
27. Mitogenic activity and cytokine levels in nonhealing and healing chronic leg ulcers
28. Interleukin-1 enhances epidermal wound healing
29. Expression of interleukin-1 alpha, interleukin-6, and basic fibroblast growth factor by cultured skin substitutes before and after grafting to full-thickness wounds in athymic mice
30. Platelet-derived interleukin-1 induces cytokine production but not proliferation of human vascular smooth muscle cells
31. Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: What we do and do not know about cytokine regulation
32. Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host response to sublethal endotoxemia
33. Interleukin-1 receptor antagonist reduces mortality from endotoxin shock
34. A recombinant human receptor antagonist to interleukin-1 improves survival after lethal endotoxemia in mice
35. An overview of mortality risk prediction in sepsis
36. Cachectin/TNF or IL-1 alpha induces cachexia with redistribution of body proteins
37. Cytokine production in a model of wound healing: The appearance of MIP-1, MIP-2, cachectin/TNF and IL- 1
38. The effect of interleukin-1 beta or transforming factor-beta on radiation-impaired murine skin wound healing
39. Interleukin-1 alpha and collagenase activity are elevated in chronic wounds
40. Stimulation of human dermal fibroblasts with interleukin 2
41. The effect of interleukin-2 administration on wound healing in adriamycin-treated rats
42. Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF)
43. Impaired immune and acute-phase responses in interleukin-6 deficient mice
44. Interleukin-6 is the major regulator of acute phase response protein synthesis in adult human hepatocytes
45. Cytokines and acute phase protein expression
46. Interleukin-6 and the acute phase response
47. Endotexemia elicits increased circulating beta 2-IFN/IL- 6 in man
48. Increased plasma levels of interleukin-6 in sepsis
49. Interleukin-6 activity in wounds
50. Correlation between interleukin-6 and matrix metalloprotease-9 in early wound healing in children
51. Effects of interleukin-6 and its neutralizing antibodies on peritoneal adhesion formation and wound healing
52. Endothelial cell surface alkaline phosphatase activity is induced by IL-6 released during wound repair
53. Basal and induced amounts of interleukin-6 MRNA decline progressively with age in human fibroblasts
54. Diminished interleukin-6 (IL-6) production during scarless human fetal wound repair
55. Prognostic value of cytokine concentrations (tumor necrosis factor-alpha, interleukin-6, and interleukin-10) and clinical parameters in severe meliodosis
56. Blood cytokine levels rise even after minor surgical trauma
57. High circulating levels of IL-6 in patients with septic shock: Evolution during sepsis, prognostic value and interplay with other cytokines
58. Marked increase in plasma interleukin-6 in burn patients
59. Circulating interleukin-6 receptor in patients with sepsis syndrome
60. Detection of interleukin-8 and tumor necrosis factor in normal humans after intravenous endotoxin: The effects of anti-inflammatory agents
61. Diminished interleukin-8 production in the fetal wound healing response
62. Neutrophilactivating peptide-1/interleukin-8, a novel cytokine that activates neutrophils
63. Chemokines IL-8, GROalpha, MCP-1, IP-10, and Mig are sequentially and differentially expressed during phase-specific infiltration of leukocyte subsets in human wound healing
64. Distributions of melanoma growth stimulatory activity of growth-regulated gene and the interleukin-8 receptor B in human wound repair
65. Low-energy helium-neon laser irradiation stimulates interleukin-1 alpha and interleukin-8 release from cultured human keratinocytes
66. Interleukin-8 is induced in skin equivalents and is highest in those derived from psoriatic fibroblasts
67. Mediators of inflammationinjury
68. Inhibition of collagen lattice contraction by pentoxifylline and interferonalpha, -beta, and -gamma asp
69. Transforming growth factor-beta mRNA and protein in hypertrophic scar tissues and fibroblasts: Antagonism by IFN-alpha and IFN-gamma in vitro and in vivo
70. Interferon-gamma coordinately upregulates matrix metalloprotease (MMP)-1 and MMP-3, but not tissue inhibitor of metalloproteases, expression in cultured keratinocytes
71. Keloid excision and recurrence prophylaxis via intradermal interferon-gamma injections: A pilot study
72. Systemic administration of interferongamma impairs wound healing
73. Systemic and local administration of interferon-gamma impairs wound healing
74. An update on interleukin-4 and its receptor
75. Functions of IL-4 and control of its expression
76. Converging and diverging properties of human interleukin-4 and interleukin-10
77. Mast cell involvement in normal human skin wound healing: Expression of monocyte chemoattractant protein-1 is correlated with recruitment of mast cells which synthesize interleukin-4 in vivo
78. Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin-4
79. Stimulation of sulphated glycosaminoglycan and decorin production in adult dermal fibroblasts by recombinant human interleukin-4
80. IL-4 upregulates tenascin synthesis in scleroderma and healthy skin fibroblasts
81. Interleukin-10 inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes
82. Regulatory role of endogenous interleukin-10 in cutaneous inflammatory response of murine wound healing
83. Comparison of IL-10 levels in chronic venous insufficiency ulcers and autologous donor tissue
84. The role of growth factors in wound healing
85. Role of platelet-derived growth factor in wound healing
86. Plateletderived growth factor induced fetal wound fibrosis
87. Reduced expression of PDGF and PDGF receptors during impaired wound healing
88. Selective modulation of collagen gene expression by different isoforms of platelet-derived growth in experimental wound healing
89. Effects of heterodimeric isoform of platelet-derived growth factor PDGF-AB on wound healing in the rat
90. Detection of platelet-derived growth factor (PDGF)-AA in actively healing human wounds treated with recombinant PDGF-BB and the absence of PDGF in chronic nonhealing wounds
91. Effects of homodimeric isoforms of platelet-derived growth factor (PDGF-AA and PDGF-BB) on wound healing in rat
92. PDGF and TGF-alpha act synergistically to improve wound healing in the genetically diabetic mouse
93. Platelet-derived growth factor and wound contraction in the rat
94. Temporal expression of TGF-beta 1. EGF and PDGF-BB in a model of colonic wound healing
95. EGF and TGF-alpha in wound healingrepair
96. Transforming growth factor-beta in tissue fibrosis
97. TGF-beta 1 accelerates wound healing: Reversal of steroid-impaired healing in rats and rabbits
98. Influence of methylprednisolone and transforming growth factor-beta on wound healing
99. Activation of collagen gene expression in keloids: Co-localization of type I and VI collagen and transforming growth factor-β mRNA
100. Enhanced expression mRNA for transforming growth factor-β type I and III procollagen in human post-burn hypertrophic scar tissues
101. TGF-beta induces fibrosis in a fetal wound model
102. Immunohistochemical localization of growth factors in fetal wound healing
103. Transforming growth factors beta 1, beta 2, and beta 3, and their receptors are differentially regulated during normal and impaired wound healing
104. Neutralisadon of TGF-beta1 and TGF-beta2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring
105. Control of scarring in adult wounds by neutralising antibody to transforming growth factor-β
106. 1,2 reduces cutaneous scarring in adult rodents
107. Wound healing: Biologic and clinical features
108. Growth factor-induced acceleration of tissue repair through direct and inductive activities in a rabbit dermal ulcer model
109. Basic fibroblast growth factor stimulation of epidermal wound healing in pigs
110. Recombinant human basicfibroblastic growth factor: Different medical dressings for clinical application in wound healing
111. Effects of collagen matrix containing basic fibroblast growth factor on wound contraction
112. Platelet-derived growth factor (BB homodimer), transforming growth factor-beta 1, and basic fibroblast growth factor in dermal wound healing: Neovessel and matrix formation and cessation of repair
113. PDGF and FGF stimulate wound healing in the genetically diabetic mouse
114. Application of basic fibroblast growth factor may reverse diabetic wound healing impairment
115. Basic fibroblast growth factor accelerates wound healing in chronically ischaemic tissue
116. Fibroblast growth factor reserves the bacterial retardation of wound contraction
117. Basic fibroblast growth factor (bFGF) and wound healing: A multi-centers and controlled clinical trial in 1024 cases
118. Effects of keratinocyte growth factor-2 on wound healing in an ischemia-impaired rabbit ear model and on scar formation
119. The function of KGF in morphogenesis of epithelium and reepithelialization of wounds
120. Induction of keratinocyte growth factor expression is reduced and delayed during wound healing in the genetically diabetic mouse
121. Suppression of keratinocyte growth factor expression by glucocorticoids in vitro and during wound healing
122. Human keratinocyte growth factor effects in a porcine model of epidermal wound healing
123. Keratinocyte growth factor-2 accelerates wound healing in incisional wounds
124. Topical application of epidermal growth factor onto partial-thickness wounds in human volunteers does not enhance reepithelialization
125. Aging fibroblasts present reduced epidermal growth factor (EGF) responsiveness due to preferential loss of EGF receptors
126. Fetal fibroblast contraction of collagen matrices in vitro: The effects of epidermal growth factor and transforming factor-beta
127. In vivo transfer and expression of a human epidermal growth factor gene accelerates wound repair
128. Acceleration of partial-thickness burn wound healing with topical application of heparin-binding EGF-like growth factor (HB-EGF)
129. Nitric oxide triggers enhanced induction of vascular endothelial growth factor expression in cultured keratinocytes (HaCaT) and during cutaneous wound repair
130. Vascular endothelial growth factor mediates angiogenic activity during the proliferative stage of wound healing
131. Plastic surgical perspectives on vascular endothelial growth factor as gene therapy for angiogenesis
132. Vascular endothelial growth factor induced by hynpoxia may mediate hypoxia-initiated angiogenesis
133. Vascular endothelial growth factor is more important than basic fibroblastic growth factor during ischemic wound healing
134. Differential expression and localization of insulin-like growth factors I and II in cutaneous wounds of diabetic nondiabetic mice
135. Insulin-like growth factors I and II expression in the healing wound
136. Insulin-like growth factor-I and -II and their role in the re-epithelialisation of wounds: Interaction with insulin-like growth factor binding protein type 1
137. Autocrine control of wound repair by insulin-like growth factor-I in cultured endothelial cells
138. Insulin-like growth factor-I reverses the impairment of wound healing induced by corticosteroids in rats
139. Insulin-like growth factor-I reverses diabetes-induced wound healing impairment in rats
140. IGF-1 gene transfer in thermally injured rats
141. Chronic wounds
142. A phase II study to evaluate recombinant platelet-derived growth factor-BB in the treatment of stage 3 and 4 pressure ulcers
143. Becaplermin gel in the treatment of pressure ulcers
144. Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers: Diabetic Ulcer Study Group
145. Balance of interleukin-1 beta and interleukin-1 receptor antagonist in human periapical lesions
146. Detection and characterization of Il-1 receptor antagonist in tissues from healthy rabbits: Il-1 receptor antagonist is probably involved in health
147. Primary structure and functional expression from complimentary DNA of human interleukin-1 receptor antagonist
148. Interleukin 1 (IL-1) receptor antagonist binds to the 80-kDa IL-1 receptor but does not initiate IL-1 signal transduction
149. Differential regulation IL-1 and IL-1 receptor antagonist in HaCaT keratinocytes by tumor necrosis factor-alpha and transforming growth factor-beta 1
150. Hypertrophic scars, keloids, and contractures
151. Keloids and excessive dermal scarring
152. Evaluation of various methods of treating keloids and hypertrophic scars: A 10-year follow-up study
153. The effect of TGF-beta on keloid fibroblast proliferation and collagen synthesis
154. Gene-enhanced tissue engineering: Applications for wound healing using cultured dermal fibroblasts transduced retrovirally with the PDGF-B gene
155. Collagen-embedded platelet-derived growth factor DNA plasmid promoted wound healing a dermal ulcer model
156. The use of newborn rats and an adenoviral gene delivery vector as a model system for wound-healing research
157. Characterization of an aFGF gene expression vector with therapeutic potential
158. Gene therapy for plastic and reconstructive surgery